Drug intelligence / Profile preview

ZYMOX

Development stage
Unknown
Lead developer
Pet King Brands
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
Administration
Topical, Otic, Oral
01

Overview

ZYMOX is a brand name associated with two distinct therapeutic categories: a veterinary enzymatic system for topical infections and a human oral antibiotic. The veterinary line, developed by PKB Animal Health, features the patented LP3 Enzyme System, which consists of three essential enzymes—lactoperoxidase, glucose oxidase, and lysozyme—often supplemented with lactoferrin. This system exerts a broad-spectrum antimicrobial effect by disrupting microbial cell walls and metabolic pathways, making it effective against bacterial, fungal, and yeast infections (including MRSA and *Pseudomonas*) in companion animals. Some veterinary formulations also include hydrocortisone to manage inflammation and pruritus. Separately, in certain international markets, Zymox is used as a trade name for amoxicillin, a beta-lactam antibiotic manufactured by companies such as Alkem Laboratories and Smilax Pharmaceuticals, indicated for human respiratory, urinary, and systemic bacterial infections.

Brand names
ZYMOXZYMOX OticZYMOX Enzymatic Ear Solution
Other names
LP3 Enzyme SystemLP-3 Enzyme SystemLP 3 Enzyme System
02

Targets

PGN (Peptidoglycan)

Beyond the preview

Go deeper on ZYMOX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZYMOX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call